Atlas Trials

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Clinical trial NCT06234748 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06234748
Sponsor
University of Michigan Rogel Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharynx CancerHPV-Related Carcinoma
Start date
2023-12-20
Primary completion
2028-07-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.